Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/09/2023 | 8.61% | UBS | $289 → $297 | Maintains | Neutral |
11/06/2023 | 9.71% | Truist Securities | $270 → $300 | Maintains | Hold |
10/20/2023 | 26.17% | Roth MKM | → $345 | Initiates Coverage On | → Buy |
10/02/2023 | 20.68% | Citigroup | $342 → $330 | Maintains | Buy |
09/05/2023 | 15.19% | B of A Securities | → $315 | Upgrades | Neutral → Buy |
08/17/2023 | 18.85% | RBC Capital | → $325 | Reiterates | Outperform → Outperform |
08/07/2023 | 9.71% | Morgan Stanley | $295 → $300 | Maintains | Equal-Weight |
08/07/2023 | 22.51% | Barclays | $321 → $335 | Maintains | Overweight |
07/19/2023 | 13.37% | Truist Securities | $300 → $310 | Maintains | Hold |
07/12/2023 | 18.85% | RBC Capital | $315 → $325 | Maintains | Outperform |
06/05/2023 | 15.19% | RBC Capital | → $315 | Reiterates | → Outperform |
05/25/2023 | 13.37% | Argus Research | $285 → $310 | Maintains | Buy |
05/03/2023 | 25.07% | Citigroup | $326 → $342 | Maintains | Buy |
05/02/2023 | 6.78% | Deutsche Bank | $260 → $292 | Maintains | Hold |
05/02/2023 | 15.19% | RBC Capital | $288 → $315 | Maintains | Outperform |
05/02/2023 | 14.46% | BTIG | $299 → $313 | Maintains | Buy |
05/02/2023 | 26.17% | Jefferies | $320 → $345 | Maintains | Buy |
05/02/2023 | 15.19% | JP Morgan | $285 → $315 | Maintains | Overweight |
05/02/2023 | 20.68% | Stifel | $280 → $330 | Maintains | Buy |
05/02/2023 | 7.88% | Morgan Stanley | $280 → $295 | Maintains | Equal-Weight |
05/02/2023 | 13.37% | Piper Sandler | $280 → $310 | Maintains | Overweight |
05/02/2023 | 7.88% | Canaccord Genuity | $250 → $295 | Maintains | Hold |
05/02/2023 | 15.19% | Baird | $287 → $315 | Maintains | Outperform |
05/02/2023 | 22.87% | Wells Fargo | $285 → $336 | Maintains | Overweight |
05/02/2023 | 17.39% | Barclays | $314 → $321 | Maintains | Overweight |
04/17/2023 | 9.34% | BTIG | $281 → $299 | Maintains | Buy |
04/17/2023 | 9.71% | Truist Securities | $275 → $300 | Maintains | Hold |
04/17/2023 | 14.1% | Loop Capital | $290 → $312 | Maintains | Buy |
04/03/2023 | 19.22% | Citigroup | $290 → $326 | Maintains | Buy |
03/31/2023 | 17.02% | Jefferies | $292 → $320 | Maintains | Buy |
03/29/2023 | 4.96% | UBS | → $287 | Initiates Coverage On | → Neutral |
03/28/2023 | -8.58% | Canaccord Genuity | → $250 | Reiterates | → Hold |
02/21/2023 | 4.22% | Argus Research | $270 → $285 | Maintains | Buy |
02/02/2023 | 3.49% | Barclays | $265 → $283 | Maintains | Overweight |
02/01/2023 | 2.4% | Morgan Stanley | $260 → $280 | Maintains | Equal-Weight |
02/01/2023 | 4.22% | Wells Fargo | $281 → $285 | Maintains | Overweight |
02/01/2023 | 6.05% | Loop Capital | $245 → $290 | Maintains | Buy |
02/01/2023 | 2.76% | BTIG | $268 → $281 | Maintains | Buy |
02/01/2023 | -8.58% | Canaccord Genuity | $220 → $250 | Maintains | Hold |
02/01/2023 | 5.32% | RBC Capital | $284 → $288 | Maintains | Outperform |
02/01/2023 | 0.57% | Truist Securities | $257 → $275 | Maintains | Hold |
02/01/2023 | 4.96% | Baird | $240 → $287 | Maintains | Outperform |
02/01/2023 | 6.05% | Citigroup | $282 → $290 | Maintains | Buy |
02/01/2023 | 2.4% | Piper Sandler | $250 → $280 | Maintains | Overweight |
01/31/2023 | -6.02% | Truist Securities | $252 → $257 | Maintains | Hold |
01/25/2023 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
01/09/2023 | 3.86% | RBC Capital | $240 → $284 | Upgrades | Sector Perform → Outperform |
01/06/2023 | -4.92% | Morgan Stanley | $220 → $260 | Maintains | Equal-Weight |
12/20/2022 | -7.84% | Truist Securities | $230 → $252 | Maintains | Hold |
12/12/2022 | 2.76% | Wells Fargo | $248 → $281 | Maintains | Overweight |
12/02/2022 | -6.02% | Barclays | $239 → $257 | Maintains | Overweight |
11/01/2022 | -9.31% | Wells Fargo | $237 → $248 | Maintains | Overweight |
11/01/2022 | -12.23% | RBC Capital | $255 → $240 | Maintains | Sector Perform |
11/01/2022 | -19.55% | Canaccord Genuity | $225 → $220 | Downgrades | Buy → Hold |
10/18/2022 | -12.6% | Barclays | → $239 | Initiates Coverage On | → Overweight |
10/17/2022 | -15.16% | BTIG | $238 → $232 | Maintains | Buy |
10/12/2022 | -1.26% | Jefferies | → $270 | Initiates Coverage On | → Buy |
09/14/2022 | -4.92% | Piper Sandler | $250 → $260 | Maintains | Overweight |
09/06/2022 | -12.96% | BTIG | $244 → $238 | Maintains | Buy |
07/28/2022 | — | Edward Jones | Upgrades | Hold → Buy | |
07/27/2022 | -13.33% | Wells Fargo | $286 → $237 | Maintains | Overweight |
07/27/2022 | -6.75% | RBC Capital | $272 → $255 | Maintains | Sector Perform |
07/27/2022 | -8.58% | Piper Sandler | $290 → $250 | Maintains | Overweight |
07/22/2022 | -18.45% | Cowen & Co. | $305 → $223 | Maintains | Outperform |
07/21/2022 | -25.03% | Deutsche Bank | $285 → $205 | Downgrades | Buy → Hold |
07/18/2022 | -10.77% | BTIG | $278 → $244 | Maintains | Buy |
07/18/2022 | -10.4% | Stifel | $285 → $245 | Maintains | Buy |
07/15/2022 | -19.55% | Morgan Stanley | $270 → $220 | Maintains | Equal-Weight |
07/11/2022 | -21.38% | B of A Securities | → $215 | Downgrades | Buy → Neutral |
05/17/2022 | 2.4% | Citigroup | $310 → $280 | Maintains | Buy |
05/02/2022 | -1.26% | Morgan Stanley | $275 → $270 | Maintains | Equal-Weight |
04/29/2022 | 6.05% | Piper Sandler | $315 → $290 | Maintains | Overweight |
04/29/2022 | 4.59% | Wells Fargo | $292 → $286 | Maintains | Overweight |
04/13/2022 | 8.25% | Truist Securities | → $296 | Initiates Coverage On | → Hold |
03/16/2022 | 7.88% | Bernstein | $288 → $295 | Upgrades | Market Perform → Outperform |
03/15/2022 | 3.86% | Evercore ISI Group | → $284 | Reinstates | → Outperform |
01/31/2022 | 0.57% | Morgan Stanley | $305 → $275 | Maintains | Equal-Weight |
01/28/2022 | -0.16% | BTIG | $280 → $273 | Maintains | Buy |
01/28/2022 | 4.22% | SVB Leerink | $300 → $285 | Maintains | Outperform |
01/07/2022 | 11.54% | Morgan Stanley | → $305 | Downgrades | Overweight → Equal-Weight |
01/04/2022 | 15.19% | Piper Sandler | $250 → $315 | Upgrades | Neutral → Overweight |
12/10/2021 | 1.66% | RBC Capital | → $278 | Initiates Coverage On | → Sector Perform |
12/07/2021 | 11.54% | Loop Capital | → $305 | Initiates Coverage On | → Buy |
11/19/2021 | 11.54% | Morgan Stanley | $295 → $305 | Maintains | Overweight |
07/28/2021 | 6.05% | Canaccord Genuity | $285 → $290 | Maintains | Buy |
07/28/2021 | 9.71% | Morgan Stanley | $280 → $300 | Maintains | Overweight |
07/28/2021 | 13.37% | Northland Capital Markets | $248 → $310 | Upgrades | Market Perform → Outperform |
07/28/2021 | 13.73% | Credit Suisse | $291 → $311 | Maintains | Outperform |
07/28/2021 | 5.32% | Oppenheimer | $273 → $288 | Maintains | Perform |
07/28/2021 | 9.71% | SVB Leerink | $290 → $300 | Maintains | Outperform |
06/01/2021 | 4.22% | Evercore ISI Group | $260 → $285 | Upgrades | In-Line → Outperform |
05/25/2021 | 2.4% | Barclays | → $280 | Initiates Coverage On | → Underweight |
04/28/2021 | 4.22% | Canaccord Genuity | $275 → $285 | Maintains | Buy |
04/28/2021 | 2.4% | Morgan Stanley | $265 → $280 | Maintains | Overweight |
04/28/2021 | 9.71% | Wells Fargo | $265 → $300 | Maintains | Overweight |
04/28/2021 | 6.05% | Raymond James | $255 → $290 | Maintains | Outperform |
02/24/2021 | -3.09% | JP Morgan | $245 → $265 | Maintains | Overweight |
01/28/2021 | -0.16% | Credit Suisse | $278 → $273 | Maintains | Outperform |
01/28/2021 | -3.09% | Morgan Stanley | $272 → $265 | Maintains | Overweight |
01/28/2021 | -6.75% | Raymond James | $240 → $255 | Maintains | Outperform |
01/06/2021 | 1.66% | Credit Suisse | $253 → $278 | Maintains | Outperform |
12/15/2020 | -0.53% | Morgan Stanley | $225 → $272 | Maintains | Overweight |
10/30/2020 | -14.43% | Canaccord Genuity | $240 → $234 | Maintains | Buy |
10/30/2020 | -14.06% | SVB Leerink | $225 → $235 | Maintains | Outperform |
10/30/2020 | -7.48% | Credit Suisse | $243 → $253 | Maintains | Outperform |
10/12/2020 | -12.23% | Raymond James | $220 → $240 | Maintains | Outperform |
10/06/2020 | -17.72% | Northland Capital Markets | → $225 | Initiates Coverage On | → Market Perform |
07/31/2020 | -21.38% | UBS | $202 → $215 | Maintains | Neutral |
07/31/2020 | -17.72% | SVB Leerink | $215 → $225 | Maintains | Outperform |
07/31/2020 | -17.72% | Morgan Stanley | $215 → $225 | Maintains | Overweight |
07/31/2020 | -11.14% | Credit Suisse | $237 → $243 | Maintains | Outperform |
07/31/2020 | -15.16% | Citigroup | $227 → $232 | Maintains | Buy |
05/11/2020 | -15.89% | Argus Research | $240 → $230 | Maintains | Buy |
05/01/2020 | -21.38% | Citigroup | $200 → $215 | Maintains | Buy |
05/01/2020 | -15.52% | CFRA | $234 → $231 | Maintains | Strong Buy |
05/01/2020 | -25.03% | Wells Fargo | $201 → $205 | Maintains | Overweight |
05/01/2020 | -26.13% | UBS | $230 → $202 | Maintains | Neutral |
05/01/2020 | -25.03% | Stifel | $145 → $205 | Maintains | Buy |
05/01/2020 | -21.38% | Morgan Stanley | $210 → $215 | Maintains | Overweight |
05/01/2020 | -13.33% | Credit Suisse | $229 → $237 | Maintains | Outperform |
04/15/2020 | -23.2% | JP Morgan | $240 → $210 | Maintains | Overweight |
04/13/2020 | -25.03% | Raymond James | $240 → $205 | Maintains | Outperform |
04/13/2020 | — | Barclays | Downgrades | Equal-Weight → Underweight | |
04/01/2020 | -26.49% | Wells Fargo | $243 → $201 | Maintains | Overweight |
04/01/2020 | -45.15% | Goldman Sachs | $248 → $150 | Downgrades | Buy → Sell |
03/27/2020 | -26.86% | Citigroup | $235 → $200 | Maintains | Buy |
03/27/2020 | -23.2% | Morgan Stanley | $250 → $210 | Maintains | Overweight |
03/24/2020 | -46.97% | Stifel | $250 → $145 | Maintains | Buy |
03/06/2020 | -9.67% | Credit Suisse | $255 → $247 | Maintains | Outperform |
03/05/2020 | -14.06% | Citigroup | → $235 | Initiates Coverage On | → Buy |
02/13/2020 | -9.31% | Goldman Sachs | → $248 | Initiates Coverage On | → Buy |
01/29/2020 | -11.14% | Deutsche Bank | $239 → $243 | Maintains | Buy |
01/29/2020 | -8.58% | Stifel | $245 → $250 | Maintains | Buy |
01/29/2020 | -9.31% | Baird | $242 → $248 | Maintains | Outperform |
01/29/2020 | -8.58% | Morgan Stanley | $242 → $250 | Maintains | Overweight |
01/08/2020 | -20.64% | SunTrust Robinson Humphrey | → $217 | Initiates Coverage On | → Hold |
12/30/2019 | -13.7% | BTIG | $228 → $236 | Maintains | Buy |
12/17/2019 | -11.5% | Morgan Stanley | $230 → $242 | Maintains | Overweight |
11/05/2019 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
10/30/2019 | -12.23% | Canaccord Genuity | $233 → $240 | Maintains | Buy |
10/30/2019 | -11.5% | Baird | $239 → $242 | Maintains | Outperform |
10/30/2019 | -10.4% | Stifel | $230 → $245 | Maintains | Buy |
10/30/2019 | -17.72% | UBS | $220 → $225 | Maintains | Neutral |
07/26/2019 | -12.6% | Baird | $206 → $239 | Maintains | Outperform |
07/26/2019 | -13.33% | Credit Suisse | $232 → $237 | Maintains | Outperform |
07/26/2019 | -12.23% | Piper Sandler | $205 → $240 | Maintains | Overweight |
07/26/2019 | -15.89% | Cantor Fitzgerald | $190 → $230 | Maintains | Neutral |
07/26/2019 | -14.79% | Canaccord Genuity | $195 → $233 | Maintains | Buy |
07/16/2019 | -15.89% | Morgan Stanley | $218 → $230 | Maintains | Overweight |
07/11/2019 | -15.16% | Credit Suisse | $200 → $232 | Maintains | Outperform |
07/02/2019 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
04/24/2019 | -30.52% | Cantor Fitzgerald | $175 → $190 | Maintains | Neutral |
04/24/2019 | -24.67% | Baird | $201 → $206 | Maintains | Outperform |
04/24/2019 | -23.93% | Deutsche Bank | $181 → $208 | Maintains | Buy |
04/24/2019 | -30.52% | Cantor Fitzgerald | $175 → $190 | Maintains | Neutral |
04/24/2019 | -28.69% | Canaccord Genuity | $190 → $195 | Maintains | Buy |
04/15/2019 | -22.84% | Barclays | $203 → $211 | Maintains | Overweight |
03/11/2019 | -25.4% | RBC Capital | $184 → $204 | Maintains | Outperform |
03/04/2019 | -20.28% | Morgan Stanley | $200 → $218 | Maintains | Overweight |
01/03/2019 | -34.54% | Deutsche Bank | → $179 | Initiates Coverage On | → Buy |
01/02/2019 | -27.96% | Morgan Stanley | $212 → $197 | Maintains | Overweight |
01/02/2019 | -38.2% | Citigroup | $174 → $169 | Maintains | Neutral |
01/02/2019 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
12/18/2018 | -28.69% | Credit Suisse | → $195 | Initiates Coverage On | → Outperform |
11/28/2018 | -34.17% | UBS | → $180 | Initiates Coverage On | → Neutral |
11/15/2018 | -36.37% | Citigroup | $173 → $174 | Maintains | Neutral |
What is the target price for Stryker (SYK)?
The latest price target for Stryker (NYSE: SYK) was reported by UBS on November 9, 2023. The analyst firm set a price target for $297.00 expecting SYK to rise to within 12 months (a possible 8.61% upside). 51 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Stryker (SYK)?
The latest analyst rating for Stryker (NYSE: SYK) was provided by UBS, and Stryker maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Stryker (SYK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stryker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stryker was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Stryker (SYK) correct?
While ratings are subjective and will change, the latest Stryker (SYK) rating was a maintained with a price target of $289.00 to $297.00. The current price Stryker (SYK) is trading at is $273.45, which is out of the analyst's predicted range.